Showing results (351-360 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|September 17, 2002
HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trialG Belcaro, M R Cesarone, P Bavera, et al.Journal of Cardiovascular Pharmacology and Therapeutics|September 17, 2002
Oxidized low-density lipoprotein receptor LOX-1 and apoptosis in human atherosclerotic lesionsD Y Li, H J Chen, E D Staples, et al.Journal of Cardiovascular Pharmacology and Therapeutics|September 17, 2002
Cariporide for pharmacologic defibrillation after prolonged cardiac arrestShue-ren Wann, Max Harry Weil, Shijie Sun, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 10, 2002
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by amiodarone: a report on two casesHaruhiko Ikegami, Tsuyoshi Shiga, Toshio Tsushima, et al.Journal of Cardiovascular Pharmacology and Therapeutics|March 26, 2003
Separate and combined effects of local and continuous intravenous administration of beta-cyclodextrin tetradecasulfate on intimal hyperplasia after angioplasty in porcine coronary arteriesNicolas F Meneveau, Bruce D Klugherz, Brahim Chaquor, et al.Journal of Cardiovascular Pharmacology and Therapeutics|March 26, 2003
Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by aspirinKailash Prasad, Paul LeeJournal of Cardiovascular Pharmacology and Therapeutics|March 26, 2003
Cardiovascular pharmacogenomics: current status, future prospectsJeffrey L Anderson, John F Carlquist, Benjamin D Horne, et al.Journal of Cardiovascular Pharmacology and Therapeutics|May 15, 2003
Tedisamil in coronary disease: additional benefits in the therapy of atrial fibrillation?Lionel H OpieJournal of Cardiovascular Pharmacology and Therapeutics|June 17, 2003
Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven?Shamil Yusuf, A John CammJournal of Cardiovascular Pharmacology and Therapeutics|June 17, 2003
Efficacy of alternate-day dosing versus daily dosing of atorvastatinMahtab Jafari, Ramin Ebrahimi, Mastaneh Ahmadi-Kashani, et al.Pageof 129